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Background: The World Health Organization created a Surgical Safety Checklist with a pause or “time out” to help
reduce preventable adverse events and improve communication. A similar tool might improve patient safety and
reduce treatment-associated morbidity in the hemodialysis unit.
Objective: To develop a Hemodialysis Safety Checklist (Hemo Pause) for daily use by nurses and patients.
Design: A modified Delphi consensus technique based on the RAND method was used to evaluate and revise the
checklist.
Setting: University-affiliated in-center hemodialysis unit.
Participants: A multidisciplinary team of physicians, nurses, and administrators developed the initial version of the
Hemo Pause Checklist. The evaluation team consisted of 20 registered hemodialysis nurses.
Measurements: The top 5 hemodialysis safety measures according to hemodialysis nurses. A 75% agreement
threshold was required for consensus.
Methods: The structured panel process was iterative, consisting of a literature review to identify safety parameters,
individual rating of each parameter by the panel of hemodialysis nurses, an in-person consensus meeting wherein
the panel refined the parameters, and a final anonymous survey that assessed panel consensus.
Results: The literature review produced 31 patient safety parameters. Individual review by panelists reduced the list to 25
parameters, followed by further reduction to 19 at the in-person consensus meeting. The final round of scoring yielded
the following top 5 safety measures: 1) confirmation of patient identity, 2) measurement of pre-dialysis weight, 3)
recognition and transcription of new medical orders, 4) confirmation of dialysate composition based on prescription, and
5) measurement of pre-dialysis blood pressure. Revision using human factors principles incorporated the 19 patient safety
parameters with greater than or equal to 75% consensus into a final checklist of 17-items.
Limitations: The literature review was not systematic. This was a single-center study, and the panel lacked patient and
family representation.
Conclusions: A novel 17-item Hemodialysis Safety Checklist (Hemo Pause) for use by nurses and patients has been
developed to standardize the hemodialysis procedure. Further quality improvement efforts are underway to explore the
feasibility of using this checklist to reduce adverse events and strengthen the safety culture in the hemodialysis unit.
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Contexte: L’Organisation mondiale de la Santé a mis au point une liste de contrôle de la sécurité chirurgicale
offrant ainsi la possibilité de faire une pause ou de « prendre du temps » pour réduire les effets indésirables qui
sont prévisibles et pour améliorer la communication. Un outil similaire pourrait améliorer la sécurité du patient et
diminuer la morbidité associée au traitement sur un service d’hémodialyse.
Objectif de l’étude: Mettre au point une liste de contrôle de la sécurité en hémodialyse (Hemo Pause) pour
utilisation quotidienne, à l’intention des infirmières et des patients.
Type d’étude: L’évaluation et la révision de la liste de contrôle ont été effectuées avec une version modifiée de
l’outil de construction de consensus Delphi, basée sur la méthode RAND.
Contexte de l’étude: Service de dialyse affilié à un centre universitaire.
Participants: La version initiale de la liste de contrôle de sécurité Hemo Pause a été mise au point par une équipe
multidisciplinaire comprenant médecins, infirmières et personnel administratif. L’équipe d’évaluation de l’outil était
formée de 20 infirmières autorisées œuvrant en hémodialyse.
Mesures: Les 5 mesures de sécurité les plus importantes, selon les infirmières en hémodialyse. Un seuil d’entente
de 75% était requis pour le consensus.
Méthodes: La méthode d’appel au panel s’est effectuée de façon itérative. Celle-ci consistait en: une revue de la
littérature afin de faire ressortir les paramètres de sécurité; l’attribution, par le panel d’infirmières en hémodialyse,
d’une valeur pour chacun des paramètres; une réunion de concertation de groupe durant laquelle le panel a raffiné
les paramètres, et, finalement, d’un questionnaire anonyme visant à évaluer le consensus atteint par le panel.
Résultats: La revue de la littérature a fait ressortir 31 paramètres de sécurité des patients. La revue individuelle faite
par les membres du panel a réduit cette liste à 25 paramètres, puis celle-ci a été de nouveau réduite à 19 lors de la
réunion de concertation de groupe. L’évaluation finale s’est soldée sur les 5 mesures de sécurité les plus importantes
suivantes: 1) la confirmation de l’identité du patient; 2) la mesure du poids du patient avant la dialyse; 3) la vérification
de nouvelles prescriptions et leur retranscription; 4) la confirmation de la composition du dialysat avec la prescription,
et 5) la mesure de la pression artérielle avant la dialyse. Utilisant des principes concernant des facteurs humains, une
révision des 19 paramètres de sécurité des patients avec un consensus plus grand ou égal à 75% a permis d’établir une
liste de contrôle finale de 17 items.
Limites de l’étude: La revue de la littérature n’était pas systématique. Cette étude s’est déroulée en un seul centre; de
plus, le panel ne représentait ni le patient ni sa famille.
Conclusions: Une liste de contrôle de la sécurité en hémodialyse (Hemo Pause) a été mise au point afin de
standardiser les traitements d’hémodialyse. Des efforts poussés d’amélioration de la qualité sont en branle afin
d’explorer la faisabilité de l’utilisation de cette liste de contrôle innovatrice pour réduire les occurrences d’événements
indésirables, et renforcer la vigilance sur les services d’hémodialyse.What was known before
Errors during in-center hemodialysis are common, and
patients often worry that an error will occur during their
hemodialysis session. Checklists are a useful patient
safety strategy that have improved care across a number
of medical disciplines.
What this adds
The first safety checklist created specifically for the
hemodialysis procedure, using a proven technique for
developing quality and patient safety measures in health-
care. This provides other dialysis facilities with an ex-
ample to produce their own patient safety tools, and
may catalyze local quality improvement efforts to en-
hance the safety of dialysis patients.Background
The “To Err is Human” report published by the Institute
of Medicine estimated that 98,000 patients die each year
from preventable medical errors in the United States [1].
Similar rates of preventable adverse events have been re-
ported in Canada [2], Australia [3], New Zealand [4,5],
and England [6]. The key lesson from these studies is
that errors are usually a result of the system of care, ra-
ther than the individual.
Patients with end-stage renal disease (ESRD) are at high
risk for medical errors given their frequency of complex
treatment, comorbidities, polypharmacy, physiological
consequences of ESRD, and coordination with other hos-
pital departments to provide care [7,8]. These factors all
contribute to a stressful and busy hemodialysis (HD) unit,
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the ESRD population.
A 2006 survey documented provider and patient opin-
ions on safety in the HD unit [9]. Frequent problems in-
cluded greater than 2 vascular access needle insertion
attempts (30%), access clotting (20%), machine difficul-
ties leading to early treatment stoppage (15%), failure to
record pre-dialysis blood pressure or weight (13%), and
access needle disconnection (5%) [9]. Almost half (49%)
of the patients who responded indicated that they are
sometimes or always worried that a mistake will occur
during their HD treatment [9].
Subsequent studies have yielded further insight into
the unique HD safety issues. A review of 526 HD inci-
dent reports to the Pennsylvania Patient Safety Authority
over a 12 month period identified medication errors
(29.0%), protocol violations (12.9%), and falls (5.9%) as
common errors during HD treatment [8]. Of these
events, 87.6% reached the patient, and 5.5% resulted in
patient harm [8]. More recently, a Scottish retrospective
study found that in 3.5% of ESRD patient deaths there
was an area of concern identified that likely contributed
to the death, and 2.1% of patient deaths were a direct re-
sult of a dialysis complication [7]. Given the frequency
and severity of errors associated with dialysis, multiple
experts have called for action [10,11].
Checklist utilization is one patient safety strategy that
may be effective. Checklists have been shown to improve
patient safety, adherence to protocols/policies, communi-
cation, teamwork, and consistency of care by standardiz-
ing procedures [12]. The pause or “time out” discussion
prior to an invasive procedure is an important component
[12]. Checklists have been effective across several disci-
plines, most notably surgery and central line insertion
[13,14]. The HD unit may be a particularly appropriate
venue for a safety checklist, where it may prevent errors
under stressful conditions and maintain staff precision,
focus, clarity, and memory recall [15].
At present, a HD safety checklist does not exist.
Therefore, our objective was to develop a HD safety
checklist using a structured, consensus-based, panel
process. Our focus was to develop a checklist that
would improve consistency of care and provider/pa-
tient communication, as well as be feasible to imple-
ment in clinical practice.
Methods
Panel members
The checklist development team consisted of 5 mem-
bers, including a nephrologist, Nephrology fellow, nurse
practitioner, nurse administrator, and researcher. Both
nursing professionals are experienced HD nurses. This
team created the pilot checklist and Delphi panel review
materials. Members were selected as a result of theirshared interests in patient safety, quality improvement,
experience as frontline HD staff, and related research
initiatives. The checklist evaluation team consisted of 20
registered HD nurses. This latter group completed the
Delphi panel process to assess the content and feasibility
of the HD safety checklist. Frontline hemodialysis staff
were involved throughout the process to ensure ongoing
input from the intended end-users of the Hemo Pause
checklist, which is an important component of success-
ful quality improvement [16].
Initial work: literature review and checklist development
A literature review was conducted to inform the con-
tent and format of the HD safety checklist. The devel-
opment team searched PubMed for relevant articles
using a search strategy that has been previously de-
scribed by the Renal Physicians Association (RPA)
[17]. Since our literature review was targeted rather
than systematic, we did not track the number of arti-
cles screened or reviewed. Bibliographies of all relevant
articles were reviewed to identify additional studies. In
addition, we conducted a focused study of select re-
sources, such as the RPA survey [9] and national HD
guidelines [18-20]. Available toolkit resources were ex-
amined in detail, including those developed by the
RPA [21], the Forum of End Stage Renal Disease Net-
works [22], and the Agency for Healthcare Research
and Quality [23].
The development team used the results of this litera-
ture review to identify patient safety parameters that
could be considered for inclusion in a HD safety check-
list. A list of these parameters was provided to A.T, a
nurse practitioner with over 30 years of HD experience,
who created the first version of the checklist. The devel-
opment team then met 3 times in person between
February 2013 and June 2013. At the first meeting, the
team reviewed the list of patient safety parameters,
evidence-based recommendations and patient safety
toolkits around best HD practices that were identified by
the literature review. When evidence was lacking, the
development team voted on whether an item would be
included on the checklist. The second meeting provided
an opportunity for individual comments and feedback
on checklist design, which was guided by examples from
the literature review. It was decided to model the check-
list after the World Health Organization (WHO) surgical
safety checklist [13], including a pause or “time out” be-
fore connecting the patient to the HD machine. A final
meeting ensured consensus of the development team on
every element of the Hemo Pause Checklist. This version
was presented to the evaluation panel. The Hemo Pause
quality improvement initiative was approved by both the
medical and nursing leadership of the in-center HD unit
at St. Michael’s Hospital in Toronto, Canada.
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A modified Delphi consensus technique, based on the
RAND method, was used [24]. We followed a structured
process through which the expertise and knowledge of a
group of individuals was systematically obtained through
questionnaires interspersed by opinion feedback. For this
study, multiple stages of the modified Delphi technique
(literature review, individual rating, face-to-face consensus
meeting, and final ranking) were used to allow for optimal,
unbiased expression of opinions (Figure 1). This is a proven
technique for developing quality and patient safety mea-
sures in healthcare [25-32].
Delphi panel ratings
In the first round, an information session was held to
introduce the evaluation team to the Hemo Pause Check-
list and the Delphi process. The participants were asked to
anonymously answer predefined standardized questions
that comprised 5 sections (Additional file 1: Figure S1).
Section 1 presented 31 patient safety parameters that
were identified by the literature review and asked the
panel which must be addressed to complete a safe HD
session (Table 1). Section 2 asked the panel to rank the
5 most important patient safety parameters from the list
of 31 parameters. At this point, the panel was shown the
pilot version of the Hemo Pause Checklist (Additional
file 2: Figure S2). Section 3 listed the patient safety pa-
rameters from section 1 that were not included in theFigure 1 Illustration of modified Delphi process.checklist, and asked the panel if any should be added.
Section 4 asked the panel to rate the checklist design
from a scale of 1 to 5, with 1 representing very poor, 3
average, and 5 excellent. Section 5 asked the panel if
there were any barriers that might interfere with check-
list completion.
Prior to the second round of the Delphi panel, the
checklist was revised based on the first round results. It
was modified using recommended human factors engin-
eering concepts by Healthcare Human Factors at
Toronto General Hospital [33]. Human factors engineer-
ing attempts to identify and address safety problems that
arise due to the interaction between people, technology,
and work environments [33].
During the second round, all panel members met in
person for a 1-day structured discussion of the results
from the first round. At the conclusion of the discussion,
members were asked to complete a second round of the
questionnaire. Individual results remained anonymous to
other panel members. After completion of all discussion
and questionnaires, panelists were asked to comment
upon the overall consensus process.
Data analysis
Consensus on the questionnaires was defined as ≥75%
agreement amongst panel members (standard percentage
in other studies) [29,30,32]. The top 5 patient safety param-
eters were calculated using a weighted frequency. A top 5
Table 1 Patient safety parameters and Delphi panel
results






Patient identification 100 100
Pre-dialysis weight 95 100
Allergies checked 95 95
Doctor’s orders noted and transcribed 95 95
Medications correctly administered 100 85
Treatment plan reviewed with patient 90 70
Patient asked about health concerns 100 85
Hand-washing 90 85
Pre-dialysis blood pressure 95 100
Easy cannulation 65 65
Correct needle insertion 80 80
Pain-free cannulation 60 20
Secured dialysis needles 85 70
Correct dialyzer 100 95
Correct dialysis solution 95 100
Correct machine setting 85 100
No circuit clotting 75 70
Blood pump speed at the prescribed rate 80 75
Blood samples collected 80 80
Blood specimens correctly labeled 95 90
Dialysis treatment for complete duration 70 45
No blood loss 80 70
Blood clotting after dialysis 75 65
No evidence of access infection 85 80
Post-dialysis blood pressure 95 100
Post-dialysis weight 90 100
No patient falls 80 80
No needle stick injuries 55 25
Medical errors reported if witnessed 60 40
Management support for incident
reporting
70 40
Adherence to procedures 80 70
*Bold font indicates a parameter with ≥75% consensus.
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number assigned by the panel. The weighted frequency was
calculated as a sum of all the points received, with a max-
imum score of 100 points indicative of the most important.
Results
Checklist development
Table 1 lists the 31 patient safety parameters identified by
the literature review. The pilot version of the checklistpresented at the first Delphi panel meeting is illustrated in
a supplementary figure (Additional file 2: Figure S2).
First round ratings
From the initial set of 31 safety parameters, 25 received
an aggregate rating of ≥75% (Table 1). The top 5 safety
measures were: 1) confirmation of patient identity (99/
100), 2) measurement of pre-dialysis weight (39/100), 3)
recognition and transcription of new medical orders (38/
100), 4) confirmation of dialysate composition based on
prescription (38/100), and 5) measurement of pre-
dialysis blood pressure (11/100). The checklist design
received a mean score of 3.75/5.
Checklist revisions
The following patient safety parameters were added to
the checklist based upon the first round results: patient
identification, patient allergies, and pre-dialysis blood
pressure. Human factors engineering helped to clarify
tasks, remove duplication, and shorten text. They rec-
ommended that hand-washing be removed from the
checklist, since it could not be easily incorporated due
to the multiple times a provider must wash their hands
during a HD session. Therefore, its inclusion on the
checklist at only one time point would be incorrect, but
its inclusion at multiple time points would be space-
consuming and cumbersome. The layout was also modi-
fied to be more consistent with the WHO Surgical
Safety Checklist [13].
Second round ratings
Analysis from the second round of panel ratings revealed
a set of 19 parameters that received an aggregate rating
of ≥75% (Table 1). All parameters with ≥75% consensus
were included in the final checklist except hand-
washing, correct needle insertion, and falls. These were
excluded due to human factors concerns, since they
were not amenable to a single and clear checklist action.
The top 5 safety measures were unchanged from the
first round. The relative weighting was 1) confirmation
of patient identity (95/100), 2) measurement of pre-
dialysis weight (58/100), 3) recognition and transcription
of new medical orders (35/100), 4) confirmation of di-
alysate composition based on prescription (32/100), and
5) measurement of pre-dialysis blood pressure (10/100).
The checklist design received a mean score of 4/5 (P =
0.09, compared to the pilot checklist, Additional file 2:
Figure S2). Frequent barriers to checklist implementa-
tion were duplication of work and time pressures, with
95% and 85% panel agreement respectively.
A post-panel survey found unanimous agreement from
the participants that their opinions were valued, the
process was fair, and that no one changed their answers
as a result of intimidation.
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Figure 2 demonstrates the final version of the Hemo
Pause Checklist. The development team unanimously
decided to include items on HD access, duration, and
anticipated adverse events, despite these items not re-
ceiving ≥75% consensus because of their strong eviden-
tiary basis or clinical face validity. This yielded a final
checklist of 17-items.
Discussion
Through a structured Delphi panel process, a HD safety
checklist (Hemo Pause) was developed using evidence-
based patient safety parameters and frontline staff ex-
perience. The decision to evaluate the checklist with a
panel of HD nurses strengthened the utility of the docu-
ment, since the intention of the checklist was for it to be
used routinely by nurses and patients during HD. This
approach helped ensure that the selected patient safety
parameters not only adhered to the general principles of
being scientifically sound, but also were clinically rele-
vant and feasible to implement.
The final list of 19 patient safety parameters that re-
ceived ≥75% consensus included actions from differentFigure 2 Final version of Hemodialysis Safety Checklist following Delptime points of the HD procedure. Several attempts were
made by the development team to incorporate all of
these parameters into the final checklist. However, hu-
man factors engineering concepts limited the inclusion
of some parameters (hand-washing, correct needle inser-
tion, and falls). As such, some parameters were excluded
to ensure that checklist tasks were clear and could be
properly integrated by frontline staff into their normal
workflow [33].
The feasibility of widely applying the HD safety check-
list was a prime consideration. It was designed to be
used collaboratively by nurses and patients at every HD
session. Not surprisingly, duplication of work and time
pressures were perceived by the panel as barriers to
checklist implementation, even prior to piloting the
checklist with patients. Several nurses also commented
that many of the checklist items are already completed
as part of usual practice. This is not surprising, since
one of the purposes of a safety checklist is to standardize
usual care, providing a barometer from which to meas-
ure errors and identify quality gaps. While these work-
load concerns can only be established by piloting the
checklist in real practice, these observations underscorehi panel process. CVC = central venous catheter.
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improvement [16,34]. Frontline staff noted that the
checklist needed to provide them with an immediate ad-
vantage, either in the form of reduced documentation or
improved patient satisfaction in order to offset the up-
front time investment required for checklist completion.
These deliverables to frontline staff will be needed to
sustain future checklist quality improvement efforts.
To our knowledge, this is the first reported safety
checklist that is uniquely geared to HD treatment. In a
systematic review of published renal replacement ther-
apy quality improvement initiatives, none of the 93 stud-
ies focused on patient safety [35]. This is an important
gap that must be filled. Previous safety efforts in dialysis
have focused on measuring the rate of preventable ad-
verse events, primarily involving voluntarily surveys [9]
or incident reporting [8]. Reporting bias is a clear limita-
tion to these methods, with variations over time more
likely to reflect changes in reporting patterns than
changes in patient safety [36]. A recent study by Bray
et al. retrospectively reviewed all dialysis deaths over a
3.5 year period to identify preventable factors that may
have contributed to mortality [7]. They identified pre-
ventable factors that may have or did contribute to death
in 3.5% of deaths. These included errors related to com-
munication, organization, and human factors, and were
due to five main causes: management of hyperkalemia,
prescribing, out of hours care, infection, and vascular ac-
cess. An accompanying editorial called upon nephrolo-
gists “to take clearly articulated steps to improve the
safety of the patients who trust them to provide care
[11]”. Examples listed included standardization, team-
work, and culture change.
Our Hemo Pause Checklist may be able to improve all
of these components. Checklists provide a reminder and
cognitive aid for tasks, such as the multistep HD proced-
ure [15]. They promote teamwork and communication,
such as those between dialysis nurses and patients [12],
which is the purpose of the pause or “time out” discus-
sion before connecting the patient to the HD machine.
Lastly, checklists highlight the importance of patient
safety, where errors represent a failure of the system ra-
ther than an individual. Despite these advantages, the
Hemo Pause Checklist should not be viewed as a universal
solution. The limitations of checklists in medicine have
been well documented, and include over-reliance, non-
adherence, and implementation challenges [15,37,38]. A
recent study of mandatory WHO Surgical Checklist use in
Ontario, Canada demonstrated no province-wide effect on
morbidity and mortality, suggesting different adherence
and implementation strategies between the 101 hospitals
[38,39]. On the other hand, the success of the Michigan
Keystone Project on reducing rates of catheter-related
bloodstream infection by 66% in 108 intensive care unitswas not only the result of a checklist, but also due to the
system change and frontline engagement that accompan-
ied its adoption [14,37,38].
Therefore, the Hemo Pause Checklist must be piloted
in the HD unit using quality improvement and change
management methods before it can be spread more
widely. This will allow for the determination of checklist
feasibility, measurement of performance gaps between
checklist and usual care, and local checklist modifica-
tions to suit the patient safety concerns and workflow of
individual HD units. We have initiated such a study in
our dialysis unit, and encourage others to evaluate
Hemo Pause in their local environments or undertake a
structured panel process to develop their own patient
safety tools.
Some limitations to our checklist development and
modified Delphi panel process require discussion. First,
the review of literature was not a systematic review,
rather it was a targeted review designed by the develop-
ment team. While it is possible that some evidence-
based safety parameters were missed, this is unlikely
given the paucity of literature that was identified. Sec-
ond, the lack of patient safety literature in dialysis means
that individual items on the checklist may not have an
extensive evidence base; however, all elements on the
checklist have clinical face validity. Third, the Delphi
panel consisted only of HD nurses at a single-center to
maximize feedback from the frontline workers for whom
the checklist was designed. Although this excluded other
important perspectives and may limit generalizability,
the HD treatment constitutes a fairly stereotyped
process with much similarity among different HD units.
Many successful checklists have been designed in single-
centers, including those from the Michigan Keystone
Project [40-43]. Moreover, to minimize selection bias,
nephrologists and administrators reviewed the final ver-
sion of the checklist, and included 3 parameters (HD ac-
cess, duration, and anticipated adverse events) that did
not reach ≥75% panel consensus but had either a strong
evidentiary basis or clinical face validity. We were unable
to obtain patient and caregiver representation on either
the development or evaluation team. Fourth, the stan-
dardized questions contained a large number of variables
available for selection. While it was imperative to in-
clude all of the major patient safety parameters that
emerged from the literature review, this has the potential
to compromise the accuracy of the Delphi method [44].
This could have contributed to a “serial position effect”,
meaning that the first factors listed were treated differ-
ently than factors listed further down [45]. We
attempted to minimize this effect by ordering the pa-
rameters according to their temporal relationship in the
HD procedure. Lastly, the potential for strong personal-
ities and opinions to dominate the direction of
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pleted the anonymous survey twice to ensure that each
participant had an opportunity to express their view.
The final survey confirmed that all participants were sat-
isfied with the process.
Our findings have important implications. Firstly, it
highlights parameters that are needed for a safe HD ses-
sion, both according to the literature and a multidiscip-
linary team of Nephrology personnel. Secondly, it
outlines the first HD safety checklist to standardize care
and communication in the HD unit. Lastly, our study
identifies barriers to checklist implementation to inform
patient safety and quality improvement efforts.
Conclusions
Patient safety is an emerging field, and there are many
opportunities in Nephrology for improvement. The
modified Delphi consensus panel approach applied in
this study enabled us to develop and evaluate the first
HD safety checklist (Hemo Pause). This methodology
and the multidisciplinary representation provide strong
face validity to the patient safety parameters included
on the checklist. We believe that these findings provide
other dialysis facilities with a roadmap to produce pa-
tient safety tools and catalyze local quality improve-
ment efforts to enhance the health and safety of dialysis
patients.
More research and testing of dialysis safety measures
are clearly needed to determine their usefulness and
feasibility. At our center, quality improvement efforts are
underway to answer these questions, as well as deter-
mine if the Hemo Pause Checklist can reduce adverse
events and strengthen the safety culture in the HD unit.
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